Finasteride 5mg

Dragon Pharma Finasteride — 5mg 5-Alpha-Reductase Inhibitor

Dragon Pharma Finasteride delivers 5 mg of Finasteride per tablet. This Type II 5-alpha-reductase inhibitor is the most scientifically validated oral agent for preventing androgenetic alopecia in genetically susceptible men.

By blocking the enzymatic conversion of testosterone to dihydrotestosterone, this compound directly addresses the hormonal mechanism that drives follicle miniaturization. It allows athletes to pursue physique goals without accelerating scalp hair loss.

Overview

Finasteride is a synthetic 4-azasteroid compound that functions as a mechanism-based inhibitor of the Type II 5-alpha-reductase isoenzyme. This enzyme catalyzes the reduction of testosterone to dihydrotestosterone in the prostate, skin, and hair follicles.

Dihydrotestosterone binds to androgen receptors in scalp follicles with approximately three times the affinity of testosterone. This triggers progressive miniaturization of the anagen phase and eventual follicular dormancy.

By suppressing systemic and scalp DHT levels by 60–70%, Finasteride halts this degenerative process. Existing follicles are preserved, and many recover to produce thicker, healthier terminal hair.

The compound is most effective when used consistently over the long term. Hair growth cycles are slow, and meaningful improvements require sustained pharmacological intervention.

Dragon Pharma manufactures each tablet with pharmaceutical precision. Independent laboratory verification ensures accurate 5 mg dosing for reliable DHT suppression.

Benefits

• Profound DHT Reduction: Suppresses scalp and serum dihydrotestosterone by up to 60–70%, directly interrupting the primary hormonal driver of follicle miniaturization.
• Halts Hair Loss Progression: Preserves existing hair density and frontal hairline in the vast majority of users, effectively pausing the genetic clock on male pattern baldness.
• Stimulates Follicular Recovery: Weakened follicles re-enter the anagen growth phase, producing thicker, healthier hair—particularly in the vertex and crown regions.
• Long-Term Preservation: With consistent daily administration, the protective effects can be maintained for years or decades without further deterioration.
• Cycle Protection: Essential safeguard during testosterone-based anabolic protocols where endogenous DHT conversion would otherwise accelerate hair thinning.

Main Features

• Precisely dosed 5 mg oral tablets for flexible micro-dosing
• Type II 5-alpha-reductase competitive inhibitor
• Blocks testosterone-to-DHT conversion in scalp and skin
• Compatible with testosterone-based anabolic cycles
• Ineffective against DHT-derivative compounds
• Independent laboratory verification of tablet potency

Ingredients

Each tablet contains 5 mg of Finasteride as the active pharmaceutical ingredient.

Inactive excipients include microcrystalline cellulose, lactose monohydrate, magnesium stearate, and pharmaceutical-grade binders to ensure tablet stability and consistent dissolution.

All raw materials undergo identity and purity validation prior to compression and film-coating.

How to Use

Ingest the tablet with water, with or without food. Consistency in daily timing supports stable plasma concentrations and optimal enzymatic inhibition.

The 5 mg tablet can be split into quarters or fifths for economical 1–1.25 mg daily dosing. Use a clean pill cutter to ensure accurate division.

Store the container in a cool, dry environment between 15–25°C (59–77°F). Protect from moisture and direct light. Keep the desiccant pouch intact.

Dosage

The standard dose for androgenetic alopecia is 1 mg daily. This is the clinically established threshold for meaningful DHT suppression and hair preservation.

The 5 mg tablet can be quartered to provide approximately 1.25 mg per piece. This is slightly above the standard dose but well-tolerated and cost-effective.

Some users experiment with 1 mg every other day or three times weekly. While this may reduce side effect incidence, daily administration provides the most robust and proven outcomes.

The original 5 mg daily dose is approved for benign prostatic hyperplasia. It offers no additional hair benefit and significantly increases adverse effect risk.

Side Effects

Sexual dysfunction is the most discussed adverse effect. A small percentage of users report decreased libido, erectile difficulty, or reduced ejaculate volume.

These manifestations typically resolve upon discontinuation. A very small subset of individuals may experience persistent symptoms known as Post-Finasteride Syndrome.

By lowering DHT, the relative estrogen-to-androgen ratio shifts. This can predispose sensitive individuals to gynecomastia, particularly when combined with aromatizing anabolic compounds.

Some users report mood alterations, depression, or cognitive fog. These may relate to changes in neurosteroid synthesis within the central nervous system.

A temporary increase in shedding during the first 1–3 months is common. This reflects the synchronization of hair follicles shifting from telogen to anagen and is a positive indicator of pharmacological activity.

Safety Information

This product is intended exclusively for research purposes and use by qualified male adults under appropriate supervision. It is not suitable for minors, women, or individuals with pre-existing hepatic or psychiatric conditions.

Women who are pregnant or may become pregnant must never handle crushed or broken tablets. Finasteride is absorbed through the skin and can cause serious fetal genital abnormalities.

Always use a pill cutter and wash hands thoroughly after handling. Do not allow contact with broken tablets by female partners or children.

Maintain an aromatase inhibitor on hand when using Finasteride alongside testosterone-based cycles. The reduced DHT may increase estrogenic sensitivity.

Discontinue immediately and seek medical evaluation if severe sexual dysfunction, breast tenderness, or mood deterioration develop.

Patience is essential. Visible improvements in hair density typically require 6–12 months of consistent use. Discontinuation reverses all benefits within months.